Logo En IconLogo Mark IconIcelandic Intellectual Property Office

SPC172

Samsetninga af: rilpivirin hýdróklóríð eða meðferðarlega jafngilt form þar af sem nýtur verndar grunneinkaleyfisins; og tenófóvír alafenamíð, eða lyfjafræðilega nothæft salt þar af, einkum tenófóvír alafenamíð fúmarat

  • Status:
    Áfrýjað
  • Application date:
    20.12.2016
  • Application published:
    15.1.2017
  • Max expiry date:
    1.9.2030
  • Next due date:
    30.9.2026
  • Medicine name:
    Odefsey
  • Medicine for children:
    No

Timeline

Today
20.12.2016Application
15.1.2017Publication
1.9.2026Expires

Marketing license

  • IS authorization number:
    EU/1/16/1112/001-002
  • Date:
    12.7.2016
  • Foreign authorization number:
    EU/1/16/1112
  • Date:
    21.6.2016

Owner

  • Name:
    Janssen Pharmaceutica NV
  • Address:
    Turnhoutseweg 30, Beerse BE

Agent

  • Name:
    Budde Schou A/S
  • Address:
    Dronningens Tværgade 30, 1302 Copenhagen K

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 15.8.2025

Expires: 1.9.2026

Payer: Árnason Faktor ehf.

Upload documents